New Era Capital Partners
Early-growth VC investing from Seed to Series B in technology companies
New Science Ventures
Backs early- and late-stage companies applying novel scientific approaches across life sciences and information technology, from biotech to autonomous mobility.
Newpath Partners
Boston-based life sciences venture firm that co-founds biotech companies with academic scientists from pre-company formation through growth.
Newtree Impact
Brussels-based impact holding investing in Agri-Food tech and food loss companies to fight climate change and reshape food systems
Nissay Capital
Corporate VC of Nippon Life Insurance since 1991, having backed over 1,000 Japanese startups with 250+ IPO exits across broad sectors.
No Label Ventures
London micro-VC backing immigrant founders as the first check, often pre-product; run solo by ex-KKR/Silver Lake investor Ramzi Rafih.
Norrsken Evolve
Stockholm pre-seed fund backing European impact-tech founders in climate, energy, health, and security with €250K initial checks plus sprints.
Norrsken Launcher
Early-stage deep tech impact fund investing €1–3M in science-driven startups with global impact potential, making 2–4 selective investments per year with deep operational involvement.
Northern Gritstone
UK investor backing deep tech and life sciences university spinouts from Leeds, Manchester, Sheffield, and Liverpool from early to growth stage.
Northern Light Venture Capital
Leading early-stage VC firm focused on enterprise tech and healthcare
Northpond Ventures
A science-driven venture capital firm building breakthrough businesses
Norwest
A global venture and growth equity investment firm managing over $15.5 billion in capital. They partner with visionary leaders to scale their businesses.
Novalis Biotech
Early-stage life sciences VC backing enabling technologies in genomics, diagnostics, bioinformatics, digital health, and research tools from pre-seed to Series A.
Novalis LifeSciences
Venture capital and private equity for breakthrough life science technologies
Novartis Venture Fund
Corporate VC investing in innovative life science companies
Nucleus Capital
First-check deep tech fund backed by the EIF investing up to €1M in technical founders building in programmable biology, food technology, and neo-industrial infrastructure across Europe and the US.
NVentures
Corporate venture capital arm of NVIDIA investing in tech visionaries across AI & computing
Nvidia Ventures
NVIDIA's corporate VC arm, pairing capital with technical platform integration and go-to-market support for AI infrastructure and robotics leaders.
NY Ventures
New York State's venture arm deploying $300M+ via direct and fund-of-funds programs since 2015; 71% of portfolio women-, minority-, or veteran-led.
NYBC Ventures
Corporate VC arm of New York Blood Center Enterprises deploying a $50M fund into early-stage companies advancing hematology, transfusion medicine, cell therapy, and infectious disease.
Oak Grove Ventures
Singapore-based VC investing in early-stage Web3, AI, and biotechnology startups, evolved from a multi-continent family office.
Obvious Ventures
Venture capital for startups reimagining trillion-dollar industries through a world positive lens
Octopus Ventures
European venture capital firm backing founders solving tomorrow's challenges
Ohio Innovation Fund
Early-stage VC based in Dublin, Ohio investing $500K–$4M in disruptive founders across AI/ML, cybersecurity, medtech, AR/VR, SaaS, and biotech with a team track record of 7 unicorns.
Showing 457–480 of 709 investors
Get the Complete BioTech Investor Database
709 investors · Stages · Sectors · Locations · CSV + Excel
Get all 709 investors →